Loading stock…

AdaptHealth Corp. (AHCO) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

AdaptHealth Corp.

AHCOMarket cap $0.77BPrice $5.8

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

AdaptHealth delivers home medical equipment and supplies — think sleep apnea machines, oxygen tanks, and diabetes devices — straight to patients' doors. It serves over 4 million Americans annually, betting big on healthcare's shift from hospitals to living rooms.

In Bastion Portfolios?

52W Return-37%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+3%4

Revenue Forecast

Rev CAGR (1y)-11%1

Rev CAGR (3y)-2%1

Rev CAGR (5y)-0%1

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+2Loss1

EPS Growth Y+3Loss1

Quality

Margins

EBIT Margin5%3

Net Income Margin-7%1

Free Cash Flow Margin3%3

Debt

Net Debt/EBITDA3.13

Efficiency

ROE-16%1

ROA-5%1

Earnings Stability11

GEAR+VERY WEAK3

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)na–

P/E Ratio (Forward 3y)na–

P/BV0.610

EV Multiples

EV/EBITDA Fwd69

EV/EBIT Fwd651

Yield

Free Cash Flow Yield12.7%10

Dividend Yieldna–

Momentum

Short term

1 month return-11%2

3 month return-43%1

YTD return-42%1

Mid term

Price vs 52wHigh43%1

1 year return-36%1

Long term

3 year return-28%1

5 year return-75%1

Risk Shield

Price Risk

Beta-0.110

Volatility68%2

Free Cash Flow

Free Cash Flow Margin3%3

Free Cash Flow Yield12.7%10

Quality

ROCE4%3

Earnings Stability11

Net Debt/EBITDA3.13

02Growth

Is it actually growing, and how fast?

AHCOAdaptHealth

Revenue FY25$3.2B

GROWTH RATING↗

VERY WEAK2 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+3%4

Revenue, next 1Y-11%1

Revenue, next 3Y, CAGR-2%1

Revenue, next 5Y, CAGR-0%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27ELoss1

EPS growth, FY28ELoss1

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 98% of companies worldwide.

Revenue is set to shrink 2%/yr over the next 3 years, behind most of the market.1/10

Revenue grew 3%/yr over the last 3 years, but it is set to shrink 2%/yr from here.

Over five years revenue is set to hold flat, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business heading into decline. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK1 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-11%2

3-month return-43%1

YTD return-42%1

MID & LONG-TERM▾SCORE

% of 52-week high43%1

1-year return-36%1

3-year return-28%1

5-year return-75%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-28% over three years and -75% over five), behind 90% of the market.

It's down 36% over the past year, now 57% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-11%), over three months (-43%) and so far this year (-42%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on AdaptHealth Corp.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

AHCOAdaptHealth

Revenue FY25$3.2B

GROWTH RATING↗

VERY WEAK2 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+3%4

Revenue, next 1Y-11%1

Revenue, next 3Y, CAGR-2%1

Revenue, next 5Y, CAGR-0%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27ELoss1

EPS growth, FY28ELoss1

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 98% of companies worldwide.

Revenue is set to shrink 2%/yr over the next 3 years, behind most of the market.1/10

Revenue grew 3%/yr over the last 3 years, but it is set to shrink 2%/yr from here.

Over five years revenue is set to hold flat, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business heading into decline. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK1 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-11%2

3-month return-43%1

YTD return-42%1

MID & LONG-TERM▾SCORE

% of 52-week high43%1

1-year return-36%1

3-year return-28%1

5-year return-75%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-28% over three years and -75% over five), behind 90% of the market.

It's down 36% over the past year, now 57% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-11%), over three months (-43%) and so far this year (-42%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on AdaptHealth Corp.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community